[Extended spectrum beta-lactamse (ESBL)-induced antibiotics resistance in gram-negative agents: what should be watched in intensive care medicine?]

A Kola; P Gastmeier

doi:10.1055/s-2003-41859

[Extended spectrum beta-lactamse (ESBL)-induced antibiotics resistance in gram-negative agents: what should be watched in intensive care medicine?]

Anasthesiol Intensivmed Notfallmed Schmerzther. 2003 Sep;38(9):573-6. doi: 10.1055/s-2003-41859.

[Article in German]

Authors

A Kola¹, P Gastmeier

Affiliation

¹ Institut für Medizinische Mikrobiologie und Krankenhaushygiene, Medizinische Hochschule Hannover, Hannover, Germany. kola.axel@mh-hannover.de

PMID: 12975735
DOI: 10.1055/s-2003-41859

Abstract

Third-generation cephalosporins have an important part in the therapy of infections due to gram-negative bacteria. Extended spectrum beta-lactamases (ESBL) are able to hydrolize these antibiotics. As the number of ESBL-producing bacteria is increasing worldwide, detection of ESBL-producers is important for the both of prevention and therapy.

Publication types

English Abstract
Review

MeSH terms

Critical Care*
Cross Infection / drug therapy
Cross Infection / microbiology*
Drug Resistance, Bacterial*
Gram-Negative Bacteria / drug effects*
Gram-Negative Bacteria / enzymology
Gram-Negative Bacterial Infections / drug therapy
Gram-Negative Bacterial Infections / microbiology*
Humans
beta-Lactamases / metabolism*

Substances

beta-Lactamases